Sonothrombolysis in acute stroke and myocardial infarction: A systematic review

Sebastiaan S. Roos, Lynda M.L. Juffermans, Jeroen Slikkerveer, Evan C. Unger, Thomas Richard Porter, Otto Kampa

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Introduction: Current treatment of patients with an acute occlusion of a cranial or a coronary artery, in for example ST segment elevation myocardial infarction (STEMI), consists of either thrombolysis or percutaneous intervention. Various thrombolytic agents (tissue plasminogen activators) are used for reperfusion therapy in patients with STEMI. However, their use may be associated with an increased risk of bleeding which is inherent to their actionmechanism. Therefore, newmethods of coronary clot resolution are being studied in an attempt to potentiate the efficacy and reduce the side effects of thrombolytics. A new method is ultrasound mediated thrombus dissolution, or sonothrombolysis. The current literature exploring sonothrombolysis is diverse in size and quality. In this systematic review of the current literature, we describe cardiovascular applications of sonothrombolysis in patients. A comparison to the neurovascular application in ischemic stroke is made, as more research has been performed on patients suffering from stroke. Methods: A systematic search was performed following the PRISMA guidelines using EMBASE and MEDLINE databases regarding sonothrombolysis in human ischemic stroke and acute myocardial infarction patients. Results: 12 original case-control or randomized controlled trials using a combination of ultrasound and microbubbles were found. 6 trials studied ischemic stroke, and 6 trials studied acute myocardial infarction. Conclusion: This systematic review provides up to date information on the subject of sonothrombolysis.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalIJC Heart and Vessels
Volume4
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Stroke
Myocardial Infarction
Microbubbles
Fibrinolytic Agents
Tissue Plasminogen Activator
MEDLINE
Reperfusion
Coronary Vessels
Thrombosis
Randomized Controlled Trials
Databases
Guidelines
Hemorrhage
Therapeutics
Research

Keywords

  • Coronary artery disease
  • Echocardiography
  • Ischemic stroke
  • Sonothrombolysis
  • Thromboembolic
  • Ultrasound contrast agents
  • events

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Sonothrombolysis in acute stroke and myocardial infarction : A systematic review. / Roos, Sebastiaan S.; Juffermans, Lynda M.L.; Slikkerveer, Jeroen; Unger, Evan C.; Porter, Thomas Richard; Kampa, Otto.

In: IJC Heart and Vessels, Vol. 4, No. 1, 01.01.2014, p. 1-6.

Research output: Contribution to journalReview article

Roos, Sebastiaan S. ; Juffermans, Lynda M.L. ; Slikkerveer, Jeroen ; Unger, Evan C. ; Porter, Thomas Richard ; Kampa, Otto. / Sonothrombolysis in acute stroke and myocardial infarction : A systematic review. In: IJC Heart and Vessels. 2014 ; Vol. 4, No. 1. pp. 1-6.
@article{dc3f810469da4b5aa59165fcd283855f,
title = "Sonothrombolysis in acute stroke and myocardial infarction: A systematic review",
abstract = "Introduction: Current treatment of patients with an acute occlusion of a cranial or a coronary artery, in for example ST segment elevation myocardial infarction (STEMI), consists of either thrombolysis or percutaneous intervention. Various thrombolytic agents (tissue plasminogen activators) are used for reperfusion therapy in patients with STEMI. However, their use may be associated with an increased risk of bleeding which is inherent to their actionmechanism. Therefore, newmethods of coronary clot resolution are being studied in an attempt to potentiate the efficacy and reduce the side effects of thrombolytics. A new method is ultrasound mediated thrombus dissolution, or sonothrombolysis. The current literature exploring sonothrombolysis is diverse in size and quality. In this systematic review of the current literature, we describe cardiovascular applications of sonothrombolysis in patients. A comparison to the neurovascular application in ischemic stroke is made, as more research has been performed on patients suffering from stroke. Methods: A systematic search was performed following the PRISMA guidelines using EMBASE and MEDLINE databases regarding sonothrombolysis in human ischemic stroke and acute myocardial infarction patients. Results: 12 original case-control or randomized controlled trials using a combination of ultrasound and microbubbles were found. 6 trials studied ischemic stroke, and 6 trials studied acute myocardial infarction. Conclusion: This systematic review provides up to date information on the subject of sonothrombolysis.",
keywords = "Coronary artery disease, Echocardiography, Ischemic stroke, Sonothrombolysis, Thromboembolic, Ultrasound contrast agents, events",
author = "Roos, {Sebastiaan S.} and Juffermans, {Lynda M.L.} and Jeroen Slikkerveer and Unger, {Evan C.} and Porter, {Thomas Richard} and Otto Kampa",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.ijchv.2014.08.003",
language = "English (US)",
volume = "4",
pages = "1--6",
journal = "IJC Heart and Vessels",
issn = "2214-7632",
publisher = "Elsevier Scientific Publishers Ireland",
number = "1",

}

TY - JOUR

T1 - Sonothrombolysis in acute stroke and myocardial infarction

T2 - A systematic review

AU - Roos, Sebastiaan S.

AU - Juffermans, Lynda M.L.

AU - Slikkerveer, Jeroen

AU - Unger, Evan C.

AU - Porter, Thomas Richard

AU - Kampa, Otto

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Introduction: Current treatment of patients with an acute occlusion of a cranial or a coronary artery, in for example ST segment elevation myocardial infarction (STEMI), consists of either thrombolysis or percutaneous intervention. Various thrombolytic agents (tissue plasminogen activators) are used for reperfusion therapy in patients with STEMI. However, their use may be associated with an increased risk of bleeding which is inherent to their actionmechanism. Therefore, newmethods of coronary clot resolution are being studied in an attempt to potentiate the efficacy and reduce the side effects of thrombolytics. A new method is ultrasound mediated thrombus dissolution, or sonothrombolysis. The current literature exploring sonothrombolysis is diverse in size and quality. In this systematic review of the current literature, we describe cardiovascular applications of sonothrombolysis in patients. A comparison to the neurovascular application in ischemic stroke is made, as more research has been performed on patients suffering from stroke. Methods: A systematic search was performed following the PRISMA guidelines using EMBASE and MEDLINE databases regarding sonothrombolysis in human ischemic stroke and acute myocardial infarction patients. Results: 12 original case-control or randomized controlled trials using a combination of ultrasound and microbubbles were found. 6 trials studied ischemic stroke, and 6 trials studied acute myocardial infarction. Conclusion: This systematic review provides up to date information on the subject of sonothrombolysis.

AB - Introduction: Current treatment of patients with an acute occlusion of a cranial or a coronary artery, in for example ST segment elevation myocardial infarction (STEMI), consists of either thrombolysis or percutaneous intervention. Various thrombolytic agents (tissue plasminogen activators) are used for reperfusion therapy in patients with STEMI. However, their use may be associated with an increased risk of bleeding which is inherent to their actionmechanism. Therefore, newmethods of coronary clot resolution are being studied in an attempt to potentiate the efficacy and reduce the side effects of thrombolytics. A new method is ultrasound mediated thrombus dissolution, or sonothrombolysis. The current literature exploring sonothrombolysis is diverse in size and quality. In this systematic review of the current literature, we describe cardiovascular applications of sonothrombolysis in patients. A comparison to the neurovascular application in ischemic stroke is made, as more research has been performed on patients suffering from stroke. Methods: A systematic search was performed following the PRISMA guidelines using EMBASE and MEDLINE databases regarding sonothrombolysis in human ischemic stroke and acute myocardial infarction patients. Results: 12 original case-control or randomized controlled trials using a combination of ultrasound and microbubbles were found. 6 trials studied ischemic stroke, and 6 trials studied acute myocardial infarction. Conclusion: This systematic review provides up to date information on the subject of sonothrombolysis.

KW - Coronary artery disease

KW - Echocardiography

KW - Ischemic stroke

KW - Sonothrombolysis

KW - Thromboembolic

KW - Ultrasound contrast agents

KW - events

UR - http://www.scopus.com/inward/record.url?scp=85027958061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027958061&partnerID=8YFLogxK

U2 - 10.1016/j.ijchv.2014.08.003

DO - 10.1016/j.ijchv.2014.08.003

M3 - Review article

AN - SCOPUS:85027958061

VL - 4

SP - 1

EP - 6

JO - IJC Heart and Vessels

JF - IJC Heart and Vessels

SN - 2214-7632

IS - 1

ER -